ATE370954T1 - Kristallform von asenapinmaleat - Google Patents
Kristallform von asenapinmaleatInfo
- Publication number
- ATE370954T1 ATE370954T1 AT06112332T AT06112332T ATE370954T1 AT E370954 T1 ATE370954 T1 AT E370954T1 AT 06112332 T AT06112332 T AT 06112332T AT 06112332 T AT06112332 T AT 06112332T AT E370954 T1 ATE370954 T1 AT E370954T1
- Authority
- AT
- Austria
- Prior art keywords
- crystal form
- asenapine maleate
- asenapine
- maleate
- crystal
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Hydrogenated Pyridines (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05102742 | 2005-04-07 | ||
| EP05102969 | 2005-04-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE370954T1 true ATE370954T1 (de) | 2007-09-15 |
Family
ID=36617328
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06112332T ATE370954T1 (de) | 2005-04-07 | 2006-04-06 | Kristallform von asenapinmaleat |
| AT06725622T ATE418556T1 (de) | 2005-04-07 | 2006-04-06 | Kristallform von asenapinmaleat |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06725622T ATE418556T1 (de) | 2005-04-07 | 2006-04-06 | Kristallform von asenapinmaleat |
Country Status (31)
| Country | Link |
|---|---|
| EP (2) | EP1710245B1 (de) |
| JP (1) | JP5058151B2 (de) |
| KR (1) | KR101422843B1 (de) |
| AR (1) | AR056306A1 (de) |
| AT (2) | ATE370954T1 (de) |
| AU (1) | AU2006231617B2 (de) |
| BR (1) | BRPI0609741A8 (de) |
| CA (1) | CA2603509C (de) |
| CY (2) | CY1106902T1 (de) |
| DE (2) | DE602006004463D1 (de) |
| DK (2) | DK1917267T3 (de) |
| DO (1) | DOP2006000082A (de) |
| ES (2) | ES2318742T3 (de) |
| GT (1) | GT200600135A (de) |
| HN (1) | HN2006014095A (de) |
| HR (1) | HRP20070429T3 (de) |
| IL (1) | IL186355A (de) |
| MX (1) | MX2007012445A (de) |
| MY (1) | MY137969A (de) |
| NO (1) | NO340520B1 (de) |
| NZ (1) | NZ562124A (de) |
| PE (1) | PE20061311A1 (de) |
| PL (2) | PL1917267T3 (de) |
| PT (2) | PT1917267E (de) |
| RS (1) | RS50532B (de) |
| RU (1) | RU2405786C2 (de) |
| SI (2) | SI1710245T1 (de) |
| SV (1) | SV2006002473A (de) |
| TW (1) | TWI364423B (de) |
| UY (1) | UY29459A1 (de) |
| WO (1) | WO2006106135A1 (de) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CL2007002891A1 (es) * | 2006-10-06 | 2008-04-18 | Organon Nv | Trans-5-cloro-2-metil-2,3,3a,12b-tetrahidro-1h-dibenz-[2,3:6,7]oxepino[4,5-c]pirrol 50% amorfo en base al peso total del compuesto; procedimiento de preparacion; composicion farmaceutica; y uso para el tratamiento de un trastorno seleccionado entre e |
| AR077225A1 (es) * | 2009-06-24 | 2011-08-10 | Organon Nv | Formulaciones inyectables que contienen asenapina y metodo de tratamiento que las utiliza |
| WO2011159903A2 (en) * | 2010-06-18 | 2011-12-22 | Dr. Reddy's Laboratories Ltd. | Asenapine maleate |
| WO2012066565A2 (en) * | 2010-11-16 | 2012-05-24 | Cadila Healthcare Limited | Asenapine maleate amorphous and crystalline form and process for preparation thereof |
| EP2468750A1 (de) | 2010-12-13 | 2012-06-27 | Chemo Ibérica, S.A. | Polymorphe Formen von Asenapinmaleat und Verfahren zur ihrer Herstellung |
| WO2012123325A1 (en) | 2011-03-11 | 2012-09-20 | Medichem S.A. | NEW CRYSTAL FORMS OF THE SALT OF TRANS-5-CHLORO-2-METHYL-2,3,3A,12b-TETRAHYDRO-1H-DIBENZO[2,3:6,7]OXEPINO[4,5-c]PYRROLE WITH MALEIC ACID |
| ITMI20110734A1 (it) * | 2011-05-02 | 2012-11-03 | Olon Spa | Sali cristallini di asenapina |
| EP2524919A1 (de) | 2011-05-17 | 2012-11-21 | Sandoz AG | Neue kristalline Salze von Asenapin mit organischen Di-Säuren und Tri-Säuren |
| EP2524920A1 (de) | 2011-05-17 | 2012-11-21 | Sandoz AG | Neue kristalline Formen von Asenapin-Hydrochloridsalz |
| EP2524921A1 (de) | 2011-05-17 | 2012-11-21 | Sandoz AG | Neue kristalline Salze von Asenapin |
| EP2709616B1 (de) * | 2011-05-18 | 2018-01-24 | Laboratorios Lesvi, S.L. | Synthese von einer stabilen mikronisierten monoklinen form des asenapinmaleates |
| US9533994B2 (en) | 2011-05-18 | 2017-01-03 | Laboratorios Lesvi S.L. | Monoclinic crystalline form of asenapine maleate with a specific particle size distribution |
| WO2013041604A1 (en) | 2011-09-21 | 2013-03-28 | Sandoz Ag | Crystal form of asenapine maleate |
| EP2572703A1 (de) | 2011-09-21 | 2013-03-27 | Hexal AG | Komprimierte orale Dosierform für Asenapinmaleat |
| CN104507472B (zh) * | 2012-07-26 | 2016-10-05 | 久光制药株式会社 | 贴附剂 |
| ITMI20121810A1 (it) | 2012-10-24 | 2014-04-25 | Chemo Iberica Sa | Poliformi di maleato di asenapina e processo per la loro preparazione |
| WO2014090386A1 (en) | 2012-12-11 | 2014-06-19 | Alfred E. Tiefenbacher (Gmbh & Co. Kg) | Orally disintegrating tablet containing asenapine |
| WO2014127786A1 (en) | 2013-02-22 | 2014-08-28 | Zentiva, K.S. | Orally disintegrating pharmaceutical composition comprising asenapine |
| EP3350194A4 (de) | 2015-09-02 | 2019-04-24 | Eloxx Pharmaceuticals Ltd. | Aminoglykosidderivate und verwendungen davon zur behandlung genetischer erkrankungen |
| AU2017384392B2 (en) | 2016-12-20 | 2023-05-25 | Lts Lohmann Therapie-Systeme Ag | Transdermal therapeutic system containing asenapine and polysiloxane or polyisobutylene |
| JP7236389B2 (ja) | 2016-12-20 | 2023-03-09 | エルテーエス ローマン テラピー－ジステーメ アーゲー | アセナピンを含有する経皮治療システム |
| EP3644973B1 (de) | 2017-06-26 | 2021-03-24 | LTS LOHMANN Therapie-Systeme AG | Transdermales therapeutisches system mit hybridem asenapin- und silikonacrylpolymer |
| BR112020026099A2 (pt) | 2018-06-20 | 2021-03-23 | Lts Lohmann Therapie-Systeme Ag | sistema terapêutico transdérmico que contém asenapina |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL7605526A (nl) * | 1976-05-24 | 1977-11-28 | Akzo Nv | Nieuwe tetracyclische derivaten. |
| HU225051B1 (en) * | 1994-03-02 | 2006-05-29 | Organon Ireland Ltd | Sublingual or buccal pharmaceutical compositions containing trans-5-chloro-2-methyl-2,3,3a,12b-tetrahydro-1h-dibenz[2,3:6,7]oxepino[4,5-c]pyrrole |
| WO1999032108A1 (en) * | 1997-12-19 | 1999-07-01 | Akzo Nobel N.V. | Org-5222 in the treatment of depression |
| TWI327915B (en) * | 2003-06-12 | 2010-08-01 | Organon Nv | Pharmaceutical composition comprising antipsychotic agent and use of the antipsychotic agent for treating patients with overweight |
-
2006
- 2006-04-06 ES ES06725622T patent/ES2318742T3/es active Active
- 2006-04-06 PT PT06725622T patent/PT1917267E/pt unknown
- 2006-04-06 EP EP06112332A patent/EP1710245B1/de active Active
- 2006-04-06 ES ES06112332T patent/ES2293626T3/es active Active
- 2006-04-06 SI SI200630006T patent/SI1710245T1/sl unknown
- 2006-04-06 WO PCT/EP2006/061408 patent/WO2006106135A1/en active Application Filing
- 2006-04-06 MY MYPI20061554A patent/MY137969A/en unknown
- 2006-04-06 GT GT200600135A patent/GT200600135A/es unknown
- 2006-04-06 DE DE602006004463T patent/DE602006004463D1/de active Active
- 2006-04-06 TW TW095112187A patent/TWI364423B/zh active
- 2006-04-06 EP EP06725622A patent/EP1917267B1/de active Active
- 2006-04-06 NZ NZ562124A patent/NZ562124A/en unknown
- 2006-04-06 AT AT06112332T patent/ATE370954T1/de active
- 2006-04-06 AR ARP060101358A patent/AR056306A1/es not_active Application Discontinuation
- 2006-04-06 RS RSP-2007/0436A patent/RS50532B/sr unknown
- 2006-04-06 DK DK06725622T patent/DK1917267T3/da active
- 2006-04-06 DO DO2006P000082A patent/DOP2006000082A/es unknown
- 2006-04-06 JP JP2008504776A patent/JP5058151B2/ja active Active
- 2006-04-06 RU RU2007141198/04A patent/RU2405786C2/ru active Protection Beyond IP Right Term
- 2006-04-06 CA CA2603509A patent/CA2603509C/en active Active
- 2006-04-06 PL PL06725622T patent/PL1917267T3/pl unknown
- 2006-04-06 PE PE2006000377A patent/PE20061311A1/es active IP Right Grant
- 2006-04-06 PT PT06112332T patent/PT1710245E/pt unknown
- 2006-04-06 BR BRPI0609741A patent/BRPI0609741A8/pt not_active IP Right Cessation
- 2006-04-06 AT AT06725622T patent/ATE418556T1/de active
- 2006-04-06 DK DK06112332T patent/DK1710245T3/da active
- 2006-04-06 KR KR1020077025428A patent/KR101422843B1/ko active IP Right Grant
- 2006-04-06 PL PL06112332T patent/PL1710245T3/pl unknown
- 2006-04-06 UY UY29459A patent/UY29459A1/es not_active Application Discontinuation
- 2006-04-06 HN HN2006014095A patent/HN2006014095A/es unknown
- 2006-04-06 SI SI200630190T patent/SI1917267T1/sl unknown
- 2006-04-06 DE DE602006000080T patent/DE602006000080T2/de active Active
- 2006-04-06 SV SV2006002473A patent/SV2006002473A/es unknown
- 2006-04-06 AU AU2006231617A patent/AU2006231617B2/en active Active
- 2006-04-06 MX MX2007012445A patent/MX2007012445A/es active IP Right Grant
-
2007
- 2007-09-19 HR HR20070429T patent/HRP20070429T3/xx unknown
- 2007-10-02 CY CY20071101258T patent/CY1106902T1/el unknown
- 2007-10-07 IL IL186355A patent/IL186355A/en active IP Right Grant
- 2007-10-10 NO NO20075142A patent/NO340520B1/no unknown
-
2009
- 2009-01-30 CY CY20091100111T patent/CY1108742T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE418556T1 (de) | Kristallform von asenapinmaleat | |
| ZA200708493B (en) | Crystal form of asenapine maleate | |
| DE602005012267D1 (de) | N von geräten | |
| DE602005011285D1 (de) | Formmasse von polymer | |
| DK1720866T3 (da) | Fremgangsmåde | |
| DK1737304T3 (da) | Flydende koncentreret formel | |
| FR2872069B1 (fr) | Vibrateur vertical | |
| ATE414693T1 (de) | Neuartige cis-imidazoline | |
| DK1700548T3 (da) | Kapsel med forseglingsmidler | |
| DE602005024107D1 (de) | Flüssigkristall wiedergabeanordnung | |
| NO20042425L (no) | Anordning for algeproduksjon | |
| ATE460162T1 (de) | Neue kristallformen von irinotecan-hydrochlorid | |
| MA28698B1 (fr) | Dicetopiperazines substituees utilisees comme antagonistes des oxytocines | |
| AT500499A3 (de) | Mittelpunktbestimmung von justiermarken | |
| NO20070299L (no) | Novel heterocyclic compounds | |
| DE602005012754D1 (de) | Kristalloszillator | |
| DE602004021510D1 (de) | Gangslichts polarisationserhaltender wellenleiterbauelemente | |
| FIU20050091U0 (fi) | Hieromalaite | |
| ATE410417T1 (de) | Kristallmodifikationen von triazinylaminostilbenen | |
| SE0402103D0 (sv) | Novel compounds | |
| UA11801S (uk) | Черепиця фронтонна | |
| SE0400661L (sv) | Husgrund | |
| FI6549U1 (fi) | Kasvuallas | |
| SE0400286D0 (sv) | Novel Compounds | |
| SE0402069D0 (sv) | Novel compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1710245 Country of ref document: EP |